HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sara Manzoni Selected Research

Polycythemia Vera

1/2021Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program.
1/2020Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sara Manzoni Research Topics

Disease

2Polycythemia Vera
01/2021 - 01/2020
1Neoplasms (Cancer)
01/2021
1Epilepsy (Aura)
01/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2005

Drug/Important Bio-Agent (IBA)

2givinostatIBA
01/2021 - 01/2020
1Janus Kinase 2IBA
01/2021
1Phenobarbital (Luminal)FDA Link
01/2020
1Gefitinib (Iressa)FDA Link
02/2005